| Phase 3 |
| NCT06855069 |
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian… |
Ovarian Cancer |
Recruiting |
2025-12-17 |
| NCT06498479 |
ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung… |
Small Cell Lung Cancer |
Recruiting |
2024-10-16 |
| NCT07821606 |
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian… |
Platinum-sensitive Recurrent Ovarian Cancer |
Not Yet Recruiting |
2026-09-16 |
| NCT07621601 |
A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal… |
Esophageal Squamous Cell Carcinoma (ESCC) |
Not Yet Recruiting |
2026-06-02 |
| NCT06935409 |
Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of… |
Osteosarcoma |
Active, Not Recruiting |
2026-04-09 |
| NCT07464327 |
A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in… |
Non-Small Cell Lung Cancer |
Not Yet Recruiting |
2026-03-11 |
| NCT06844799 |
A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis |
Moderate-to-severe Plaque Psoriasis |
Not Yet Recruiting |
2025-02-25 |
| NCT06672393 |
A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis |
Psoriasis |
Not Yet Recruiting |
2024-11-04 |
| NCT06526624 |
A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer |
Limited-stage Small-cell Lung Cancer |
Not Yet Recruiting |
2024-07-30 |
| Phase 2/3 |
| NCT06417008 |
A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous… |
Non-Squamous Non-Small Cell Lung Cancer |
Recruiting |
2025-08-01 |
| Phase 2 |
| NCT06112704 |
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors |
Advanced Solid Tumor |
Recruiting |
2024-12-02 |
| NCT06014190 |
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer |
Ovarian Cancer |
Recruiting |
2024-08-29 |
| NCT05830123 |
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other… |
Osteosarcoma |
Recruiting |
2024-08-23 |
| NCT06007729 |
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other… |
Head and Neck Squamous Cell Carcinoma |
Recruiting |
2024-08-20 |
| NCT07824882 |
A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093… |
Non-Small Cell Lung Cancer |
Not Yet Recruiting |
2026-09-17 |
| NCT06926582 |
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis |
Psoriasis |
Not Yet Recruiting |
2025-04-13 |
| NCT06635772 |
A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary… |
Immunoglobulin a Nephropathy |
Not Yet Recruiting |
2024-10-10 |
| NCT06594965 |
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk… |
Myelodysplastic Syndromes |
Not Yet Recruiting |
2024-09-19 |
| Phase 1/2 |
| NCT07283367 |
A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer… |
CRC |
Recruiting |
2026-05-01 |
| NCT06144723 |
Study of HS-20105 for Injection in Patients With Advanced Solid Tumors. |
Advanced Solid Tumor |
Not Yet Recruiting |
2023-11-22 |
| Phase 1 |
| NCT07775703 |
HS-20117-2 Injection in Patients With Advanced Solid Tumors |
Advanced Solid Tumors |
Recruiting |
2026-08-20 |
| NCT07645222 |
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC |
Lung Cancer |
Recruiting |
2026-07-06 |
| NCT06936735 |
A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors |
Advanced Solid Tumor |
Recruiting |
2026-06-02 |
| NCT06892379 |
A Study of HS-20110 in Participants With Advanced Solid Tumors |
Solid Tumors |
Recruiting |
2026-04-20 |
| NCT07462923 |
HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma |
Advanced Gastric and Gastroesophageal Junction Adenocarcinoma |
Recruiting |
2026-03-10 |